FTO and nonpapillary renal cell carcinoma: To determine the role of pyrimidines and ROS in FTO-mediated ccRCC growth and survival, we performed clonogenic assays in FB23-2–treated cells alone and in combination with pyrimidine nucleobases and NAC.